Suppr超能文献

阿尔茨海默病及相关痴呆症诊断的潜在新方法

Potential New Approaches for Diagnosis of Alzheimer's Disease and Related Dementias.

作者信息

Turner R Scott, Stubbs Terry, Davies Don A, Albensi Benedict C

机构信息

Department of Neurology, Georgetown University, Washington, DC, United States.

ActivMed, Practices & Research, Methuen, MA, United States.

出版信息

Front Neurol. 2020 Jun 5;11:496. doi: 10.3389/fneur.2020.00496. eCollection 2020.

Abstract

Dementia is an umbrella term-caused by a large number of specific diagnoses, including several neurodegenerative disorders. Alzheimer's disease (AD) is now the most common cause of dementia in advanced countries, while dementia due to neurosyphilis was the leading cause a century ago. Many challenges remain for diagnosing dementia definitively. Some of these include variability of early symptoms and overlap with similar disorders, as well as the possibility of combined, or mixed, etiologies in some cases. Newer technologies, including the incorporation of PET neuroimaging and other biomarkers (genomics and proteomics), are being incorporated into revised diagnostic criteria. However, the application of novel diagnostic methods at clinical sites is plagued by many caveats including availability and access. This review surveys new diagnostic methods as well as remaining challenges-for clinical care and clinical research.

摘要

痴呆是一个概括性术语,由大量特定诊断引起,包括几种神经退行性疾病。在发达国家,阿尔茨海默病(AD)现在是痴呆最常见的病因,而一个世纪前,神经梅毒所致痴呆是主要病因。明确诊断痴呆仍存在许多挑战。其中一些挑战包括早期症状的变异性、与类似疾病的重叠,以及在某些情况下病因合并或混合的可能性。包括正电子发射断层扫描(PET)神经成像和其他生物标志物(基因组学和蛋白质组学)在内的新技术正在被纳入修订后的诊断标准。然而,新诊断方法在临床场所的应用受到诸多限制,包括可用性和可及性。本综述调查了新的诊断方法以及临床护理和临床研究中仍然存在的挑战。

相似文献

1
Potential New Approaches for Diagnosis of Alzheimer's Disease and Related Dementias.
Front Neurol. 2020 Jun 5;11:496. doi: 10.3389/fneur.2020.00496. eCollection 2020.
4
5
Clinical indications for analysis of Alzheimer's disease CSF biomarkers.
Rev Neurol (Paris). 2013 Oct;169(10):709-14. doi: 10.1016/j.neurol.2013.07.024. Epub 2013 Sep 6.
9
Clinical-neuropathological correlations in Alzheimer's disease and related dementias.
Arch Neurol. 1994 Sep;51(9):888-95. doi: 10.1001/archneur.1994.00540210060013.
10
Neuroimaging in Dementias.
Semin Neurol. 2019 Apr;39(2):188-199. doi: 10.1055/s-0039-1678580. Epub 2019 Mar 29.

引用本文的文献

1
Real-world use of diagnostic tests for mild cognitive impairment, Alzheimer's disease, and other dementias in Medicare fee-for-service beneficiaries.
Alzheimers Dement (Amst). 2025 Aug 4;17(3):e70156. doi: 10.1002/dad2.70156. eCollection 2025 Jul-Sep.
2
Exploring the potential of probiotics in Alzheimer's disease and gut dysbiosis.
IBRO Neurosci Rep. 2024 Nov 8;17:441-455. doi: 10.1016/j.ibneur.2024.11.004. eCollection 2024 Dec.
3
Gut microbial metabolism in Alzheimer's disease and related dementias.
Neurotherapeutics. 2024 Oct;21(6):e00470. doi: 10.1016/j.neurot.2024.e00470. Epub 2024 Oct 28.
5
Prediction of Alzheimer's disease progression within 6 years using speech: A novel approach leveraging language models.
Alzheimers Dement. 2024 Aug;20(8):5262-5270. doi: 10.1002/alz.13886. Epub 2024 Jun 25.
7
Application of CRISPR/Cas9 System in the Treatment of Alzheimer's Disease and Neurodegenerative Diseases.
Mol Neurobiol. 2024 Nov;61(11):9416-9431. doi: 10.1007/s12035-024-04143-2. Epub 2024 Apr 19.
9
From Recognition to Remedy: The Significance of Biomarkers in Neurodegenerative Disease Pathology.
Int J Mol Sci. 2023 Nov 9;24(22):16119. doi: 10.3390/ijms242216119.
10
Schltdl. & Cham., HPLC Profile, and Neuroprotective Potential via Regulation of JNK, miRNA132, and miRNA-125b.
ACS Omega. 2023 Jul 21;8(30):27238-27246. doi: 10.1021/acsomega.3c02562. eCollection 2023 Aug 1.

本文引用的文献

2
Development and validation of a salivary tau biomarker in Alzheimer's disease.
Alzheimers Dement (Amst). 2018 Apr 21;11:53-60. doi: 10.1016/j.dadm.2018.03.003. eCollection 2019 Dec.
3
Impact of a Clinical Decision Support Tool on Dementia Diagnostics in Memory Clinics: The PredictND Validation Study.
Curr Alzheimer Res. 2019;16(2):91-101. doi: 10.2174/1567205016666190103152425.
4
Neuroimaging and Machine Learning for Dementia Diagnosis: Recent Advancements and Future Prospects.
IEEE Rev Biomed Eng. 2019;12:19-33. doi: 10.1109/RBME.2018.2886237. Epub 2018 Dec 11.
5
The repeatable battery for the assessment of the neuropsychological status (RBANS): a diagnostic validity study in Greek elderly.
Aging Clin Exp Res. 2019 Sep;31(9):1305-1312. doi: 10.1007/s40520-018-1076-9. Epub 2018 Nov 23.
6
CDSS-RM: a clinical decision support system reference model.
BMC Med Res Methodol. 2018 Nov 16;18(1):137. doi: 10.1186/s12874-018-0587-6.
7
Systematic Review on Resting-State EEG for Alzheimer's Disease Diagnosis and Progression Assessment.
Dis Markers. 2018 Oct 4;2018:5174815. doi: 10.1155/2018/5174815. eCollection 2018.
8
A Deep Learning Model to Predict a Diagnosis of Alzheimer Disease by Using F-FDG PET of the Brain.
Radiology. 2019 Feb;290(2):456-464. doi: 10.1148/radiol.2018180958. Epub 2018 Nov 6.
9
Five-factor structure of the RBANS is supported in an Alzheimer's disease sample: Implications for validation of neuropsychological assessment instruments.
Appl Neuropsychol Adult. 2020 May-Jun;27(3):232-242. doi: 10.1080/23279095.2018.1529671. Epub 2018 Oct 31.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验